SCHEMBL22861902

SCHEMBL22861902

COc1c(C(C)C)c(O)c(O)c2c1C(OC)C1OC(O)C23CCCC(C)(C)C13

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22861901 0.78 FDPS (0.40) —
Taiwaniaquinol C SCHEMBL31237206 0.61 PIK3CA (0.33) —
Fortunin C SCHEMBL18290293 0.60 FDPS (0.42) —
Taiwaniaquinol B SCHEMBL31237215 0.59 USP2 (0.37) —
Taiwaniaquinol B SCHEMBL18105238 0.59 USP2 (0.37) —
Taiwaniaquinol E SCHEMBL31237185 0.59 USP2 (0.37) —
SCHEMBL12249339 0.57 USP2 (0.37) —
SCHEMBL31238108 0.57 FDPS (0.61) —
SCHEMBL5589697 0.57 AKR1B1 (0.41) —
SCHEMBL18290240 0.55 FDPS (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210000841-A1 COMPOUNDS THAT MODULATE VON WILLEBRAND FACTOR LEVELS AND THEIR USE IN THE TREATMENT OF BLOOD DISORDERS SOCIETE DES PRODUITS NESTLE S.A. (CH) 2021-01-07 — — US disclosed
Send feedback